Current Status and Future Directions in the Development of Digital Therapeutic Interventions for Neurodevelopmental...

Area of Science:

• Digital health innovations
• Therapeutic technology development
• Neurodevelopmental disorder treatments

Background:

• Digital therapeutics (DTx) are emerging as a new class of medical interventions.
• DTx show promise as theranostics for conditions with diverse diagnostic profiles, such as neurodevelopmental diseases (NDDs).
• Successful development and deployment of DTx for NDDs face significant hurdles.

Purpose of the Study:

• To review the challenges in developing and implementing DTx for NDDs.
• To analyze these challenges from the perspectives of patients, healthcare professionals, and manufacturers.
• To discuss implications and propose future strategies for advancing DTx in NDD care.

Main Methods:

• Literature review of digital therapeutics and neurodevelopmental diseases.
• Analysis of challenges in DTx development and deployment.
• Synthesis of perspectives from patients, medical professionals, and manufacturers.

Main Results:

• Identified key challenges in DTx development for NDDs across patient, provider, and industry domains.
• Highlighted the implications of these challenges on therapeutic efficacy and accessibility.
• Outlined critical factors hindering widespread adoption and effective implementation.

Conclusions:

• DTx development for NDDs requires addressing multifaceted challenges.
• Future directions focus on revitalizing DTx innovation through collaborative strategies.
• Overcoming identified barriers is crucial for realizing the potential of DTx in NDD management.